Comments on "dynamic 18F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer"

被引：0
|
作者：
Wang, Shan-Ying [1 ,2 ]
Shiau, Yu-Chien [1 ]
Hsu, Chen-Xiong [2 ,3 ]
机构：
[1] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan
[3] Far Eastern Mem Hosp, Dept Radiol, Div Radiat Oncol, New Taipei 220, Taiwan
来源：
THORACIC CANCER | 2022年 / 13卷 / 24期
关键词：
18F-FDG PET/CT; volume-based metabolic parameters; SUV; metabolic tumor volume; total lesion glycolysis;
D O I：
10.1111/1759-7714.14710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3513 / 3514
页数：2
相关论文
共 50 条
  • [21] Correction: The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer
    Guo, Rui
    Yan, Wanpu
    Wang, Fei
    Su, Hua
    Meng, Xiangxi
    Xie, Qing
    Zhao, Wei
    Yang, Zhi
    Li, Nan
    CANCER IMAGING, 2024, 24 (01)
  • [22] The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer
    Tao, Xiuli
    Li, Ning
    Wu, Ning
    He, Jie
    Ying, Jianming
    Gao, Shugeng
    Wang, Shuhang
    Wang, Jie
    Wang, Zhijie
    Ling, Yun
    Tang, Wei
    Zhang, Zewei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (05) : 1209 - 1219
  • [23] The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer
    Xiuli Tao
    Ning Li
    Ning Wu
    Jie He
    Jianming Ying
    Shugeng Gao
    Shuhang Wang
    Jie Wang
    Zhijie Wang
    Yun Ling
    Wei Tang
    Zewei Zhang
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 1209 - 1219
  • [24] Early prediction of response to chemotherapy in non-small cell lung cancer patients using 18F-FDG PET/CT
    Laine, Richard
    Wells, Karen
    Heidel, Robert
    Schaefferkoetter, Joshua
    Long, Misty
    Hubner, Karl
    Hanna, Wahid
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [25] Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT
    Nahmias, Claude
    Hanna, Wahid T.
    Wahl, Lindi M.
    Long, Misty J.
    Hubner, Karl F.
    Townsend, David W.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (05) : 744 - 751
  • [26] 18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy
    Evangelista, Laura
    Cuppari, Lea
    Menis, Jessica
    Bonanno, Laura
    Reccia, Pasquale
    Frega, Stefano
    Pasello, Giulia
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (08) : 802 - 807
  • [27] Diagnostic value of dynamic 18F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes
    Sun, Yishan
    Xiao, Liming
    Wang, Yanmei
    Liu, Changping
    Cao, Li
    Zhai, Wei
    Wang, Bo
    Yu, Shupeng
    Xin, Jun
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (04) : 2556 - 2567
  • [28] Predicting Major Pathological Response to Neoadjuvant Immunochemotherapy in Non-small Cell Lung Cancer Using Multi- organ 18F-FDG PET Metabolic Parameters: A Preliminary Study
    Ma, Q.
    Li, J.
    Tang, Y.
    Hu, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S503 - S503
  • [29] Parameters of FDG PET/CT Predicting Pathological Response to Neoadjuvant Immunotherapy in Stage II/III Non-small Cell Lung Cancer Patients
    Lee, E. S.
    Choi, J.
    Lee, J. H.
    Jo, K. H.
    Eo, J. S.
    Kim, H. K.
    Yong, H. S.
    Lee, S. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S567 - S568
  • [30] Comparison of 18F-FDG PET/CT and MDCT for staging/restaging of non-small cell lung cancer
    Sobic-Saranovic, D.
    Petrusic, I.
    Artiko, V.
    Pavlovic, S.
    Subotic, D.
    Saranovic, D.
    Nagorni-Obradovic, L.
    Petrovic, N.
    Todorovic-Tirnanic, M.
    Odalovic, S.
    Grozdic-Milojevic, I.
    Stoiljkovic, M.
    Obradovic, V.
    NEOPLASMA, 2015, 62 (02) : 295 - 301
12345